University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Triptorelin

For endometriosis or breast cancer.

Status: Amber Triptorelin (Decapeptyl® SR)
Status: Amber Ursodeoxycholic acid
Status: Amber Valproic acid as semisodium valproate tablets

Specialist initiation only

Status: Amber Vigabatrin tablets

ESCA

Status: Amber Vitamin and mineral supplements (Ketovite)

Tablets and liquid.

Status: Amber Vitamins A and D capsules

Specialist recommendation.

Status: Amber Vortioxetine (Brintellix)

Specialist initiation only and RICaD

Status: Amber Warfarin tablets

First choice. BSSE APC preferred agent. This recommendation must only be taken into account after a patient and prescriber have discussed all treatment options (including warfarin) and only if they have no preference about which medicine they want to use. To be initiated by those who have the appropriate skills and experience.

Use should be in line with local commissioning arrangements - for BCC CCG - Anticoagulation AQP. Ensure that patients prescribed anticoagulants receive appropriate verbal and written information at the start of therapy, at hospital discharge, on the first anticoagulant clinic appointment, and when necessary throughout the course of their treatment (NPSA Alert 18)

Status: Amber Xalacom eye drops

Specialist ophthalmologist recommendation

Building healthier lives
Back to top